Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Assessment of pancreatic characteristics using spectral CT imaging

Official title: Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT Feature Parameters: A Related Study

Run by Shengjing Hospital · NCT06510036 · Data updated 2026-11-12

This study is testing a new type of CT scan to see if it can help doctors better understand pancreatic diseases by looking at how the pancreas works and what might be wrong with it.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment1500 (estimated)
SponsorShengjing Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedJanuary 21, 2021
Main results expectedJune 21, 2027
Study endsJune 21, 2028
Registry record updatedDecember 4, 2024
Trial IDNCT06510036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have undergone CT scans involving the pancreas at the hospital since March 2024.

Probably not a fit

Patients with previous pancreatic surgery, severe systemic diseases, or excessive pancreatic atrophy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves patients who have undergone CT scans of the pancreas at Shengjing Hospital starting in January 2024. It collects and analyzes spectral CT data to evaluate both physiological and pathological characteristics of pancreatic tissue. The study utilizes dual-energy CT technology to quantify parameters such as iodine uptake and extracellular volume, aiming to develop models that correlate these findings with traditional CT data and patient health status. The goal is to enhance the understanding of pancreatic diseases and improve diagnostic accuracy.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic techniques for pancreatic diseases, allowing for earlier and more accurate detection.

How similar studies have gone: Other studies utilizing dual-energy CT have shown promise in improving diagnostic capabilities, suggesting this approach may be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1.Since March 2024, I have been visiting our hospital for various reasons and have undergone CT scans involving the pancreas (using energy spectrum CT)

Exclusion Criteria:

1. Previous pancreatic surgery with incomplete pancreatic tissue.
2. Severe systemic diseases that result in severe organ dysfunction
3. Excessive pancreatic atrophy or other reasons cannot accurately delineate ROI

Where it's running

  • Shengjing Hospital of China Medical University
    Shenyang, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.